StonvexLoading…
StonvexStonvexStonvexCore line items from PZZA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-28 | Annual 2024 2024-12-29 | Annual 2023 2023-12-31 | Annual 2022 2022-12-25 |
|---|---|---|---|---|
Revenue | $2.05B | $2.06B | $2.14B | $2.10B |
Operating Income | $89.15M | $156.70M | $147.14M | $109.03M |
Net Income | $30.53M | $83.49M | $82.10M | $67.77M |
EPS (Diluted) | $0.90 | $2.54 | $2.48 | $1.89 |
Total Assets | $837.51M | $888.95M | $875.00M | $864.23M |
Total Liabilities | $1.27B | $1.30B | $1.32B | $1.13B |
Cash & Equivalents | $34.59M | $37.95M | $40.59M | $47.37M |
Free Cash Flow OCF − CapEx | $61.30M | $34.15M | $116.44M | $39.42M |
Shares Outstanding | 32.80M | 32.60M | 32.50M | 34.70M |